RPID - Rapid Micro Biosystems Sales Growth YoY (Last 12 Months)

Brandmark of Rapid Micro Biosystems, Inc. (RPID)

The unwavering trust of global pharma behemoths in Rapid Micro Biosystems (RPID) contrasts with the internal success of a disciplined management team that has implemented a transparent subscription model. The year-over-year sales trend over a 12-month period demonstrates growth dynamics, with the value recorded at 20.60. The company's innovative optical systems have radically accelerated microbiological control, ensuring the highest safety standards in the production of modern vaccines.

Sales Growth YoY (TTM): Rapid Micro Biosystems (RPID) for 02/11/2024 - 11/17/2026

Summary analytical data breakdowns for Rapid Micro (RPID)

- market value and analyst target forecast:
Fundamental company valuation:rapidmicrobio.com
Original product of Rapid Micro Biosystems Inc.

Rapid Micro Biosystems (RPID) automates microbiological control in pharmaceuticals by implementing the Growth Direct system to minimize production defects. The current 12-month YoY revenue growth rate of 20.60 reflects the actual dynamics of market share expansion, measuring the percentage change in sales over a rolling year to isolate organic growth from inflationary effects.